Literature DB >> 9144723

Molecular mobility of supercooled amorphous indomethacin, determined by dynamic mechanical analysis.

V Andronis1, G Zografi.   

Abstract

PURPOSE: To determine the viscosity and the frequency-dependent shear modulus of supercooled indomethacin as a function of temperature near and above its glass transition temperature and from these data to obtain a quantitative measure of its molecular mobility in the amorphous state.
METHODS: Viscoelastic measurements were carried with a controlled strain rheometer in the frequency domain, at 9 temperatures from 44 degrees to 90 degrees C.
RESULTS: The viscosity of supercooled indomethacin shows a strong non-Arrhenius temperature dependence over the temperature range studied, indicative of a fragile amorphous material. Application of the viscosity data to the VTF equation indicates a viscosity of 4.5 x 10(10) Pa.s at the calorimetric Tg of 41 degrees C. and a T0 of -17 degrees C. From the complex shear modulus and the Cole-Davidson equation the shear relaxation behaviour is found to be non-exponential, and the shear relaxation time at Tg is found to be approximately 100 sec.
CONCLUSIONS: Supercooled indomethacin near and above its Tg exhibits significant molecular mobility, with relaxation times similar to the timescales covered in the handling and storage of pharmaceutical products.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9144723     DOI: 10.1023/a:1012026911459

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  6 in total

1.  Dynamic viscosity of a simple glass-forming liquid.

Authors: 
Journal:  Phys Rev Lett       Date:  1994-08-15       Impact factor: 9.161

2.  A kinetic study of the crystallization process of noncrystalline indomethacin under isothermal conditions.

Authors:  M Otsuka; N Kaneniwa
Journal:  Chem Pharm Bull (Tokyo)       Date:  1988-10       Impact factor: 1.645

3.  Crystallization of indomethacin from the amorphous state below and above its glass transition temperature.

Authors:  M Yoshioka; B C Hancock; G Zografi
Journal:  J Pharm Sci       Date:  1994-12       Impact factor: 3.534

4.  Stability and several physical properties of amorphous and crystalline form of indomethacin.

Authors:  H Imaizumi; N Nambu; T Nagai
Journal:  Chem Pharm Bull (Tokyo)       Date:  1980-09       Impact factor: 1.645

5.  Inhibition of indomethacin crystallization in poly(vinylpyrrolidone) coprecipitates.

Authors:  M Yoshioka; B C Hancock; G Zografi
Journal:  J Pharm Sci       Date:  1995-08       Impact factor: 3.534

6.  Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures.

Authors:  B C Hancock; S L Shamblin; G Zografi
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

  6 in total
  20 in total

1.  Usefulness of the Kohlrausch-Williams-Watts stretched exponential function to describe protein aggregation in lyophilized formulations and the temperature dependence near the glass transition temperature.

Authors:  S Yoshioka; Y Aso; S Kojima
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

2.  The activation energy at Tg and the fragility index of indomethacin, predicted from the influence of the heating rate on the temperature position and on the intensity of thermally stimulated depolarization current peak.

Authors:  Joaquim J Moura Ramos; Natália T Correia; Raquel Taveira-Marques; George Collins
Journal:  Pharm Res       Date:  2002-12       Impact factor: 4.200

3.  A mechanistic investigation of an amorphous pharmaceutical and its solid dispersions, part II: molecular mobility and activation thermodynamic parameters.

Authors:  Rama A Shmeis; Zeren Wang; Steven L Krill
Journal:  Pharm Res       Date:  2004-11       Impact factor: 4.200

4.  Comparison of molecular mobility in the glassy state between amorphous indomethacin and salicin based on spin-lattice relaxation times.

Authors:  Katsuhiko Masuda; Sachio Tabata; Yasuyuki Sakata; Tetsuo Hayase; Etsuo Yonemochi; Katsuhide Terada
Journal:  Pharm Res       Date:  2005-05-17       Impact factor: 4.200

5.  Time-dependence of molecular mobility during structural relaxation and its impact on organic amorphous solids: an investigation based on a calorimetric approach.

Authors:  Chen Mao; Sai Prasanth Chamarthy; Rodolfo Pinal
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

6.  Estimating the critical molecular mobility temperature (T(K)) of amorphous pharmaceuticals.

Authors:  B C Hancock; K Christensen; S L Shamblin
Journal:  Pharm Res       Date:  1998-11       Impact factor: 4.200

7.  The molecular mobility of supercooled amorphous indomethacin as a function of temperature and relative humidity.

Authors:  V Andronis; G Zografi
Journal:  Pharm Res       Date:  1998-06       Impact factor: 4.200

8.  Role of viscosity in influencing the glass-forming ability of organic molecules from the undercooled melt state.

Authors:  Jared A Baird; Darlene Santiago-Quinonez; Carlos Rinaldi; Lynne S Taylor
Journal:  Pharm Res       Date:  2011-07-22       Impact factor: 4.200

9.  Solubility of small-molecule crystals in polymers: D-mannitol in PVP, indomethacin in PVP/VA, and nifedipine in PVP/VA.

Authors:  Jing Tao; Ye Sun; Geoff G Z Zhang; Lian Yu
Journal:  Pharm Res       Date:  2008-12-04       Impact factor: 4.200

10.  The effect of low concentrations of molecularly dispersed poly(vinylpyrrolidone) on indomethacin crystallization from the amorphous state.

Authors:  Kieran J Crowley; George Zografi
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.